ThermoDox: Clinical Trials

7 trials of ThermoDox, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 2 withdrawn, 1 terminated, 1 unknown. 3 Phase 1, 2 Phase 2, 2 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 13Completed 1, Unknown 1, Withdrawn 1
Phase 22Terminated 1, Withdrawn 1
Phase 32Completed 2

Follow ThermoDox: new trials by email Literature Review of ThermoDox trials Research Report on ThermoDox

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Pilot Study of Thermodox and MR-HIFU for Treatment of Relapsed Solid Tumors
Magnetic Resonance-Guided High Intensity Focused Ultrasound, Lyso-thermosensitive Liposomal Doxorubicin - Solid Tumors, Soft Tissue Sarcoma
Phase 2WithdrawnChildren's National Research Institute2022-11-102025-01-01
PanDox: Targeted Doxorubicin in Pancreatic Tumours
Focused Ultrasound, Doxorubicin, ThermoDox - Pancreatic Ductal Adenocarcinoma, Pancreatic Cancer Stage IV
Phase 1WithdrawnUniversity of Oxford2021-06-162023-04-12
Image-guided Targeted Doxorubicin Delivery With Hyperthermia to Optimize Loco-regional Control in Breast Cancer
LTLD, MR-HIFU induced hyperthermia, Cyclophosphamide - Metastatic Breast Cancer, Breast Cancer
Phase 1UnknownUMC Utrecht122021-03-012021-02-17
Study of ThermoDox With Standardized Radiofrequency Ablation (RFA) for Treatment of Hepatocellular Carcinoma (HCC)
ThermoDox, Dummy infusion - Hepatocellular Carcinoma
Phase 3CompletedImunon5542014-06-012024-08-20
Phase 2 Study of Thermodox as Adjuvant Therapy With Thermal Ablation (RFA) in Treatment of Metastatic Colorectal Cancer(mCRC)
Lyso-Thermosensitive Liposomal Doxorubicin, 5% Dextrose Solution, ThermoDox - Colon Cancer Liver Metastasis
Phase 2TerminatedImunon22011-09-012022-10-13
Phase 3 Study of ThermoDox With Radiofrequency Ablation (RFA) in Treatment of Hepatocellular Carcinoma (HCC)
ThermoDox, 5% Dextrose Solution - Hepatocellular Carcinoma
Phase 3CompletedImunon7012008-05-012024-05-03
A Study of ThermoDox™ in Combination With Radiofrequency Ablation (RFA) in Primary and Metastatic Tumors of the Liver
ThermoDox - Hepatocellular Carcinoma, Liver Neoplasms
Phase 1CompletedImunon302007-02-012019-02-07

Conditions studied

Carcinoma, Hepatocellular (4)  ·  Liver Neoplasms (4)  ·  Carcinoma (2)  ·  Hyperthermia (2)  ·  Neoplasms (2)  ·  Adenocarcinoma (1)  ·  Breast Neoplasms (1)  ·  Carcinoma, Ductal, Breast (1)  ·  Colonic Neoplasms (1)  ·  Digestive System Diseases (1)  ·  Digestive System Neoplasms (1)  ·  Liver Diseases (1)  ·  Neoplasm Metastasis (1)  ·  Neoplasms by Histologic Type (1)  ·  Neoplasms by Site (1)

Sponsors

Imunon (4)  ·  Children's National Research Institute (1)  ·  UMC Utrecht (1)  ·  University of Oxford (1)

Countries

United States (5)  ·  Canada (2)  ·  China (2)  ·  Hong Kong (2)  ·  Italy (2)  ·  Malaysia (2)  ·  Philippines (2)  ·  South Korea (2)  ·  Taiwan (2)  ·  Thailand (2)  ·  Germany (1)  ·  Japan (1)  ·  Netherlands (1)  ·  Singapore (1)  ·  Spain (1)

Top investigators

AeRang Kim, MD, PhD (1)  ·  Britt BM Suelmann, MD (1)  ·  Chen Min Hua, MD (1)  ·  Mark Middleton (1)  ·  Nicholas Borys, M.D. (1)  ·  Ricardo Lencioni, MD (1)  ·  Riccardo Lencioni, M.D. (1)  ·  Ronnie T Poon, M.D. (1)  ·  Ronnie Tung Ping Poon, MD (1)

Results publications

PMID 33243800, PMID 37741968

NIH funding

2015 (1)